Article
GSR Mediates Cisplatin Resistance in Oral Cancer by Protecting Mitochondria
2023-09-06
Abstract excerpt
<h4>Background: </h4> The existing cisplatin chemotherapy treatment for recurrent or metastatic oral squamous cell carcinoma (R/M OSCC) has been the conventional treatment, and it is also a relatively effective treatment method to improve the survival rate of patients. However, due to the resistance of tumor cells to chemotherapy, the treatment effect is poor. So far, the causes of chemotherapy resistance of tumor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3661249-e1cc-5874-8fa6-728a789db933
- DOI
- 10.21203/rs.3.rs-3311956/v1
